2765676-20-6
Chemical Structure
CDK7-IN-13
- CAS No.: 2765676-20-6
- Formula:C20H23F3N6OS
- Molecular Weight:452.50
IUPAC Name: (S)-dimethyl((3-(2-(piperidin-3-ylamino)-5-(trifluoromethyl)pyrimidin-4-yl)-1H-indol-7-yl)imino)-l6-sulfanone
InChIKey: HALSANFRDIZFSB-LBPRGKRZSA-N
SMILES: CS(C)(=O)=NC1=CC=CC2=C1NC=C2C3=NC(N[C@H]4CCCNC4)=NC=C3C(F)(F)F
Biological Activity: CDK7-IN-13 is a potent inhibitor of CDK7. CDK7-IN-13 is a pyrimidinyl derivative compound. CDK7-IN-13 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 1)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDK7-IN-13 | CDK7-IN-13 is a potent inhibitor of CDK7. CDK7-IN-13 is a pyrimidinyl derivative compound. CDK7-IN-13 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 1). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
